I'd like to ask something and if I am way off base
Post# of 36536
(Total Views: 368)
Posted On: 03/09/2021 9:24:59 AM
I'd like to ask something and if I am way off base, please forgive me.
But, the last CC had issues. not with the science information, because we received a lot of information on the science It was good. But on the ability of shareholders to ask questions.
The test results were successful. Everyone, the company, the shareholders, the partners were all waiting for the results and we all found out the test was successful. We are all HAPPY.
We know they are putting in the IND.
We couldn't ask what steps if test is successful, how does it impact the deals while waiting on IND in China or Malaysia or does it add not more value to NGIO uplist. We could not ask any questions about if there would be a two front approach on getting it approved one here and one overseas.
But we do not know what is happening surrounding that. We couldn't ask any questions on the CC about how it impacts ongoing deals. We couldn't ask about anything, because the CC call in wasn't working.
It should be the responsibility of the company to come out with a PR or to have another CC to explain everything and not leave the shareholders hanging for weeks asking themselves all of these questions, which we are asking, which everyone knows, Joe and others from the company are probably reading on boards, literally day after day and not answering.
To put it bluntly, this is not taking care of shareholders or future investors.
When an issue occurs on a CC that impacts the communication with their shareholders, the company needs to make it right to get their message out to the shareholders so everyone knows what is going on with the deals, with the overall progress. Shareholders have invested millions and millions in the company.
In this day and age, information is the key.
We are now into the second week of March and silence. How long is this going to go on?
But, the last CC had issues. not with the science information, because we received a lot of information on the science It was good. But on the ability of shareholders to ask questions.
The test results were successful. Everyone, the company, the shareholders, the partners were all waiting for the results and we all found out the test was successful. We are all HAPPY.
We know they are putting in the IND.
We couldn't ask what steps if test is successful, how does it impact the deals while waiting on IND in China or Malaysia or does it add not more value to NGIO uplist. We could not ask any questions about if there would be a two front approach on getting it approved one here and one overseas.
But we do not know what is happening surrounding that. We couldn't ask any questions on the CC about how it impacts ongoing deals. We couldn't ask about anything, because the CC call in wasn't working.
It should be the responsibility of the company to come out with a PR or to have another CC to explain everything and not leave the shareholders hanging for weeks asking themselves all of these questions, which we are asking, which everyone knows, Joe and others from the company are probably reading on boards, literally day after day and not answering.
To put it bluntly, this is not taking care of shareholders or future investors.
When an issue occurs on a CC that impacts the communication with their shareholders, the company needs to make it right to get their message out to the shareholders so everyone knows what is going on with the deals, with the overall progress. Shareholders have invested millions and millions in the company.
In this day and age, information is the key.
We are now into the second week of March and silence. How long is this going to go on?
(9)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼